By exploring practical examples, you will gain an understanding of the PAGB medicines advertising codes and the PAGB copy clearance process, as well as the system of advertising self-regulation operated in the UK.
The workshop covers:
The workshops are aimed at anyone involved with the advertising and promotion of OTC medicines such as marketing and regulatory professionals and their agency colleagues, as well as sales and medical information.
Workshops are held at PAGB’s central London offices from 10.00 am to 4.00 pm. They are facilitated by members of the PAGB regulatory and copy clearance teams. The facilitators use a combination of presentations and case studies during the sessions and encourage integration and questions. Delegates receive a pack of information, containing copies of the presentations, practical examples and other useful materials, to take away with them.
PAGB members and associate members: £375 + VAT @ 20%
Non-members: £1000 + VAT @ 20%
PAGB members and associate members: £395 + VAT @ 20%
Non-members: £1185 + VAT @ 20%
For further information about the workshops, please contact firstname.lastname@example.org or call 020 7242 8331.
“It was a great way to train multiple functions within our business and talk about specific areas which were pertinent to our particular products and projects’’ – Director of Regulatory Affairs, Pfizer Consumer Healthcare UK
“I found the Medicines advertising workshop very useful, particularly to understand how the rules are interpreted, with lots of practical examples. This one day session was interactive and gave me the right level of information about OTC medicines advertising and packaging.” – Annae Liu, Bayer
“The PAGB’s advertising code sessions always prompt fresh thinking about the brands we work on, particularly through the use of current case studies and updates on legislation. Even if you’re convinced you know it all and have worked in the industry for years, you will come away from these meetings thinking differently about your brands and seeing new opportunities.” – Actavis